RadNet, Inc. (RDNT)
| Market Cap | 4.23B -0.8% |
| Revenue (ttm) | 2.14B +14.7% |
| Net Income | -14.19M |
| EPS | -0.19 |
| Shares Out | 78.63M |
| PE Ratio | n/a |
| Forward PE | 73.62 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,522,418 |
| Open | 53.55 |
| Previous Close | 53.74 |
| Day's Range | 52.88 - 55.95 |
| 52-Week Range | 50.76 - 85.84 |
| Beta | 1.39 |
| Analysts | Strong Buy |
| Price Target | 89.75 (+67.01%) |
| Earnings Date | Aug 10, 2026 |
About RDNT
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for RDNT stock is "Strong Buy." The 12-month stock price target is $89.75, which is an increase of 67.01% from the latest price.
News
RadNet Secures $250 Million Incremental Term Loan to Fund Strategic Growth Opportunities and Reduces the Interest Rates on its Credit Facility by 0.25%
LOS ANGELES, June 10, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services th...
DeepHealth Launches Reporting Pro, Bringing AI Automation to Radiology Reporting
SOMERVILLE, Mass., June 10, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced t...
RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities
LOS ANGELES, June 03, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services th...
RadNet to Host Men's Health Webinar on June 13, 2026
RadNet hosts free webinar for Men's Health Month, featuring live Q&A and physicians presenting on coronary artery disease, prostate cancer and lung cancer.
RadNet Earnings Call Transcript: Q1 2026
Record Q1 revenue and EBITDA were achieved despite weather impacts, driven by advanced imaging growth, strong Digital Health momentum, and successful acquisitions. Guidance for 2026 was raised, with robust cash flow and margin improvements expected as integration and AI deployment continue.
RadNet Earnings release: Q1 2026
RadNet released its Q1 2026 earnings on May 11, 2026, summarizing the period's financial results.
RadNet Quarterly report: Q1 2026
RadNet has published its Q1 2026 quarterly earnings report on May 11, 2026.
RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow
LOS ANGELES, May 10, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a netw...
RadNet and Trinity Health's Saint Alphonsus Health System Launch a Multi-Site Joint Venture in Boise, Idaho, to Include a Broad Technology Deployment of DeepHealth Solutions
RadNet forms joint venture with Saint Alphonsus Health System in Idaho, expanding its footprint and deploying DeepHealth OS to transform radiology workflow
RadNet, Inc. Announces Date of its First Quarter 2026 Financial Results Conference Call
LOS ANGELES, April 28, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, annou...
RadNet Proxy statement: Proxy filing
RadNet filed a proxy statement on April 20, 2026, providing details for shareholder voting and corporate governance matters.
RadNet Proxy statement: Proxy filing
RadNet filed a proxy statement on April 20, 2026, providing details for shareholder voting and corporate governance matters.
GE HealthCare expands mammography collaboration with RadNet's DeepHealth subsidiary to extend global access to DeepHealth's AI-powered breast cancer screening solutions
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an expanded collaboration with DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary o...
RadNet Transcript: 2026 KeyBanc Capital Markets Healthcare Forum
Strong growth in advanced imaging and digital health, driven by acquisitions, technology upgrades, and AI innovation, is expected to continue in 2026. Hospital joint ventures and regulatory trends support expansion, while the Gleamer acquisition positions the company as a global AI leader.
RadNet Transcript: Barclays 28th Annual Global Healthcare Conference
Record revenue and margin growth were highlighted, with strong MRI and PET CT volumes and a positive 2026 outlook. Digital health is set for over 50% growth, driven by acquisitions like Gleamer, which expands AI capabilities and synergies. Labor efficiencies and advanced imaging trends support sustained margin improvement.
RadNet Transcript: M&A announcement
The acquisition of Gleamer adds advanced X-ray AI capabilities, accelerating global expansion and automated reporting initiatives. Significant cost and revenue synergies are expected, with rapid integration and deployment planned for 2024. Break-even is targeted by mid-2027.
RadNet Press release: M&A announcement
RadNet issued a press release on March 5, 2026, disclosing material business information to investors.
RadNet, Inc. Reminds Investors of the Dedicated Conference Call and Presentation About the Recently Completed Acquisition of Gleamer SAS
LOS ANGELES, March 04, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and oper...
RadNet Transcript: 47th Annual Raymond James Institutional Investor Conference
Imaging and digital health revenues are set for strong growth in 2026, driven by advanced imaging, acquisitions, and AI integration. Margin expansion is expected as technology and automation offset rising labor costs. Multiple FDA approvals and international expansion further support the outlook.
RadNet, Inc. to Present at the Raymond James 47th Annual Institutional Investors Conference on Tuesday, March 3rd, 2026
LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned an...
RadNet Transcript: Investor update
RadNet's acquisition of Gleamer, integrated into DeepHealth, creates the largest radiology AI provider globally, with a combined portfolio covering over 75 indications and strong financial growth projections. The integration accelerates automation in diagnostics, enhances operational efficiency, and positions the entity as a leader in clinical AI.
RadNet Earnings Call Transcript: Q4 2025
Record Q4 and full-year 2025 results were driven by strong imaging and Digital Health growth, major acquisitions, and robust cash flow. The Gleamer acquisition positions the company as a global AI leader, with 2026 guidance projecting double-digit revenue and ARR growth.
RadNet Earnings release: Q4 2025
RadNet released its Q4 2025 earnings on March 2, 2026, summarizing the period's financial results.
RadNet Annual report: Q4 2025
RadNet has published its Q4 2025 annual report on March 2, 2026.
RadNet Reports Fourth Quarter 2025 Results, Including Record Revenue and Adjusted EBITDA⁽¹⁾ and Releases 2026 Financial Guidance
LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a ne...